RG
NVO

Rathbones Group’s Novo Nordisk NVO Stock Holding History

Rathbones Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.76M Sell
57,524
-24,358
-30% -$1.05M 0.01% 275
2026
Q1 		$3.01M Buy
81,882
+8,744
+12% +$414K 0.01% 262
2025
Q4 		$3.72M Buy
73,138
+32,270
+79% +$1.65M 0.01% 245
2025
Q3 		$2.27M Sell
40,868
-1,180
-3% -$69.1K 0.01% 284
2025
Q2 		$2.9M Buy
42,048
+42
+0.1% +$2.86K 0.01% 258
2025
Q1 		$2.92M Buy
42,006
+29,993
+250% +$2.48M 0.01% 245
2024
Q4 		$1.03M Sell
12,013
-562
-4% -$60.8K 0.01% 333
2024
Q3 		$1.5M Buy
12,575
+1,805
+17% +$241K 0.01% 296
2024
Q2 		$1.54M Sell
10,770
-6,015
-36% -$797K 0.01% 284
2024
Q1 		$2.16M Buy
16,785
+265
+2% +$31.5K 0.01% 261
2023
Q4 		$1.71M Sell
16,520
-28
-0.2% -$2.77K 0.01% 269
2023
Q3 		$1.5M Buy
+16,548
New +$1.46M 0.01% 277
2022
Q4 		– Sell
-5,000
Closed -$249K – 431
2022
Q3 		$249K Hold
5,000
– – ﹤0.01% 352
2022
Q2 		$279K Hold
5,000
– – ﹤0.01% 356
2022
Q1 		$278K Hold
5,000
– – ﹤0.01% 367
2021
Q4 		$280K Hold
5,000
– – ﹤0.01% 371
2021
Q3 		$240K Hold
5,000
– – ﹤0.01% 377
2021
Q2 		$209K Buy
+5,000
New +$194K ﹤0.01% 395

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Rathbones Group's NVO Position: Q2 2026 in Review

Rathbones Group reduced its Novo Nordisk (NVO) stake by 30% in Q2 2026, selling an estimated $1.05M and leaving 57,524 shares worth $2.76M. The position accounts for 0.01% of the portfolio, ranked #275.

Rathbones Group first reported a position in NVO in Q2 2021 and has held it in 18 quarters since. The position peaked at $3.72M in Q4 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Rathbones Group held 57,524 shares of Novo Nordisk worth $2.76M as of Q2 2026.
  • Rathbones Group sold 24,358 Novo Nordisk shares in Q2 2026, an estimated $1.05M.
  • Novo Nordisk made up 0.01% of Rathbones Group's portfolio in Q2 2026, its #275 holding.
  • Rathbones Group first reported a position in Novo Nordisk in Q2 2021 and has held it in 18 quarters since.
  • Rathbones Group's Novo Nordisk position peaked at $3.72M in Q4 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Rathbones Group's 13F filing for Q2 2026, filed 23 Jul 2026.